SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacques Chitte who wrote (3070)3/26/1998 12:56:00 PM
From: clochard   of 7041
 
"SGP has already received approval to market Vasomax in Mexico; this gives the company a test market"

Interesting comment. I wonder how many drug companies are using Mexicans as unwitting Guinea pigs.

As far as the latest suit, it says that at the time (November) the product in reality had NO patent protection and as a result of the publicity of that fact, the stock price dropped and investors were screwed. The fact that it now has a patent may make the suit look trivial, but investors did suffer a loss, even though the loss was prompted by the revelation. This looks to me like the only weapon available for a lawsuit. The lack of an NDA and its eventual rejection hasn't been misrepresented (yet).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext